CANY
GERN icon

Caxton Associates (New York)’s Geron GERN Stock Holding History

Caxton Associates (New York)’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-273,327
Closed -$640K – 510
2022
Q3 		$640K Buy
+273,327
New +$612K 0.09% 193

Other funds holding GERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Caxton Associates (New York)'s GERN Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Geron (GERN) in Q4 2022, closing a stake of 273,327 shares — an estimated $640K sold.

Caxton Associates (New York) first reported a position in GERN in Q3 2022 and held it in 1 quarter. The position peaked at $640K in Q3 2022. 185 funds tracked by Wall St. Rank hold GERN as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Geron position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 273,327 Geron shares in Q4 2022, an estimated $640K.
  • Caxton Associates (New York) first reported a position in Geron in Q3 2022 and held it in 1 quarter.
  • Caxton Associates (New York)'s Geron position peaked at $640K in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Geron as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.